Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Pharmacology & Therapeutics|July 8, 2008
Early clinical development: evaluation of drug-induced torsades de pointes riskTorbjorn Vik, Chris Pollard, Philip Sager
Journal of Clinical Pharmacology|May 26, 2017
Model-Based Evaluation of Exenatide Effects on the QT Interval in Healthy Subjects Following Continuous IV InfusionBrenda Cirincione, Frank LaCreta, Philip Sager, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|October 15, 2013
Lomitapide at supratherapeutic plasma levels does not prolong the Qtc interval--results from a TQT study with moxifloxacin and ketoconazoleBorje Darpo, Georg Ferber, Meijian Zhou, et al.
Diabetes Research and Clinical Practice|October 26, 2005
Effect of rosuvastatin or atorvastatin on urinary albumin excretion and renal function in type 2 diabetic patientsJonathan Sorof, Christian Berne, Annica Siewert-Delle, et al.
Journal of Women'S Health (2002)|January 15, 2005
Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and menSusan Bennett, Philip Sager, Leslie Lipka, et al.
Drugs & Aging|January 6, 2005
Efficacy and safety of coadministration of ezetimibe and statins in elderly patients with primary hypercholesterolaemiaLeslie Lipka, Philip Sager, John Strony, et al.
Journal of Clinical Lipidology|February 5, 2011
Further reduction of low-density lipoprotein cholesterol and C-reactive protein with the addition of ezetimibe to maximum-dose rosuvastatin in patients with severe hypercholesterolemiaEvan A Stein, Leiv Ose, Kjetil Retterstøl, et al.
Journal of Biopharmaceutical Statistics|May 13, 2008
QT/QTc prolongation in placebo-treated subjects: a PhRMA collaborative data analysisMarilyn A Agin, William S Aronstein, Georg Ferber, et al.
American Heart Journal|March 20, 2012
Detection of QT prolongation using a novel electrocardiographic analysis algorithm applying intelligent automation: prospective blinded evaluation using the Cardiac Safety Research Consortium electrocardiographic databaseCynthia L Green, Paul Kligfield, Samuel George, et al.
American Heart Journal|June 15, 2016
NOAC monitoring, reversal agents, and post-approval safety and effectiveness evaluation: A cardiac safety research consortium think tankJames A Reiffel, Jeffrey I Weitz, Paul Reilly, et al.
Pageof 3